Akouos EV 2011-2026 | AKUS

EV Jährlich Akouos

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
95.1 M	499 M	51.6 M	33 M	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
499 M	33 M	170 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
BioNTech SE BNTX	-4.91 B	$ 97.57	2.17 %	$ 27.2 B	Germany
Aligos Therapeutics ALGS	82.6 M	$ 8.49	6.25 %	$ 83.9 M	USA
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.63	-2.42 %	$ 8.73 B	Australia
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	1.16 B	$ 2.15	-0.69 %	$ 447 M	USA
Evogene Ltd. EVGN	-4.88 M	$ 0.83	2.5 %	$ 27.9 M	Israel
Amphastar Pharmaceuticals AMPH	1.92 B	$ 20.87	2.45 %	$ 976 M	USA
Genmab A/S GMAB	27 B	$ 28.23	-0.07 %	$ 18 B	Danmark
Grifols, S.A. GRFS	11.8 B	$ 8.24	0.3 %	$ 6.83 B	Spain
GT Biopharma GTBP	-2.9 M	$ 0.37	-0.92 %	$ 2.04 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Halozyme Therapeutics HALO	12 B	$ 66.86	-1.42 %	$ 8.01 B	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Harmony Biosciences Holdings HRMY	1.26 B	$ 28.5	-1.35 %	$ 1.64 B	USA
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	493 M	$ 1.43	2.14 %	$ 368 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 2.91	-0.26 %	$ 4.79 M	Israel
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	540 M	$ 4.18	2.45 %	$ 447 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 23.96	-1.03 %	$ 3.05 B	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	2.07 B	$ 32.21	-0.09 %	$ 2.14 B	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.49	-0.34 %	$ 397 M	Britain
Immatics N.V. IMTX	503 M	$ 10.59	1.53 %	$ 666 M	Germany
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Incyte Corporation INCY	18.2 B	$ 94.65	-1.48 %	$ 18.5 B	USA
Cidara Therapeutics CDTX	9.99 M	-	-	$ 1.41 B	USA
Innate Pharma S.A. IPHA	259 M	$ 1.48	4.61 %	$ 235 M	France
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	-15.2 M	$ 2.57	0.78 %	$ 16.1 M	USA
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Inventiva S.A. IVA	129 M	$ 5.15	-2.09 %	$ 138 M	France
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA